|Articles|February 13, 2023
Novavax COVID Vaccine 140 Million Dose Order Canceled by Japan, Takeda Reveals
Advertisement
In 2021, Takeda announced a partnership with Novavax to manufacture 150 million doses of the Nuvaxovid COVID-19 vaccine; however, the Japanese government has canceled its order for the remaining 141.76 million doses due to low demand.
Japan's cancellation of the Novavax vaccine order will not significantly impact Takeda's finances and the company is not altering its full-year consolidated forecasts.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
2
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant
3
Pharma Roundup: Mounjaro Shows Advantages in Type 2 Diabetes, Immune System Linked to Long Covid Symptoms
4
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
5